.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
AstraZeneca
Accenture
Fish and Richardson
Argus Health
Deloitte
UBS
Boehringer Ingelheim
Queensland Health
Fuji

Generated: June 29, 2017

DrugPatentWatch Database Preview

AZULFIDINE EN-TABS Drug Profile

« Back to Dashboard

Which patents cover Azulfidine En-tabs, and what generic Azulfidine En-tabs alternatives are available?

Azulfidine En-tabs is a drug marketed by Pharmacia And Upjohn and is included in one NDA.

The generic ingredient in AZULFIDINE EN-TABS is sulfasalazine. There are ten drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the sulfasalazine profile page.

Summary for Tradename: AZULFIDINE EN-TABS

Patents:0
Applicants:1
NDAs:1
Suppliers / Packagers: see list5
Bulk Api Vendors: see list24
Clinical Trials: see list49
Patent Applications: see list6,456
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:AZULFIDINE EN-TABS at DailyMed

Pharmacology for Tradename: AZULFIDINE EN-TABS

Ingredient-typeAminosalicylic Acids
Drug ClassAminosalicylate
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
AZULFIDINE EN-TABS
sulfasalazine
TABLET, DELAYED RELEASE;ORAL007073-002Apr 6, 1983ABRXYesYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Fuji
Queensland Health
Cantor Fitzgerald
Deloitte
UBS
Boehringer Ingelheim
Cerilliant
Baxter
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot